Tech Company Financing Transactions
Octagon Therapeutics Funding Round
Octagon Therapeutics, based in Boston, secured investment capital from private investors.
Transaction Overview
Company Name
Announced On
2/16/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
The seed financing will allow Octagon to expand the scientific team and to accelerate preclinical development activities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
127 Western Ave.
Boston, MA 02134
USA
Boston, MA 02134
USA
Phone
Website
Email Address
Overview
Octagon World Headquarters is based in the Pagliuca Life Lab directly adjacent to Harvard campus. This state-of-the-art facility has allowed Octagon to accelerate the development of our vital medicines with minimal overhead and equipment costs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Isaac Stoner
Chief Scientific Officer
Fred Ausubel
Chief Technical Officer
Peter Yu
Vice President
Brent Cezairliyan
Vice President
Nathaniel Sherden
Browse more venture capital transactions:
Prev: 2/16/2018: Lydia venture capital transaction
Next: 2/16/2018: Dwolla venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs